Home > Formulary : Adult > Recent Decisions > 2017 >
Decisions 4th April 2017
At the meeting that took place on 4th April, the following decisions were agreed:
New Drug Requests
Approved
MUSE® (No SCP)
Actilyse® (alteplase)
- For use in blocked haemodialysis catheters
Further Information required
Methenamine
- Further information about the intended cohort is required.
Shared Care Protocols/TLS Change in Status
Tetracosactide 250mcg Injection TLS change Red to Amber
- TLS to remain Red
Fosfomycin TLS change Amber (No SCP) to Green
- Agreed for type 1 penicillin allergic patients
Melatonin for specialist paediatric population
- Proposed SCP reviewed, further cohort definition required
Feraccru®
- Proposed SCP reviewed, clarification of monitoring responsibilities and changes to contract to reflect changes inactivity required
Testosterone Injection
- Paediatric for Constitutional Delay of Growth and Puberty. SCP reviewed, to be reviewed by Paediatric Joint Formulary Group.
- Further information about impact on primary care required
Ticagrelor SCP update
- Updated to reflect TA420